Member - Human Tissue Authority (VAC-1420)

Closed
Body: Human Tissue Authority
Appointing Department: Department of Health
Sector: Health
Location: London
Number of Vacancies: 2
Remuneration: Remuneration for the role is £7,883 per annum.
Time Requirements: Two to three days per month

Campaign Timeline

  • Competition Launched

    28/03/2019

  • Closed for Applications

    20/05/2019 at 12:00

  • Panel Sift

    06/06/2019

  • Final Interview Date

    28/06/2019

  • Announcement

    TBC

 

Assessment Panel

Vacancy Description

Ministers are seeking to make two appointments to the board of Human Tissue Authority.

Role and Responsibilities of a Member

As a Member of the Human Tissue Authority (HTA) you will:

  • Support the Chair in setting the strategic direction of the HTA, encouraging and enabling the HTA to be a first-class regulator of human tissue;
  • Support the Chair in developing the HTA in-line with the organisation’s strategic aims while maintaining a positive, constructive and appropriate relationship with its stakeholders to ensure confidence in the work of the HTA;
  • Provide an independent view, a substantive contribution, and constructive challenge at Authority meetings and sub committees;
  • Monitor the performance of the HTA’s Executive, holding it to account for the delivery of the HTA’s business plan, HM Treasury and Department of Health and Social Care requirements.

Person Specification

To be considered, you must be able to demonstrate that you have the qualities, skills and experience to meet all the essential criteria for appointment.

  • Commitment to the objectives of the HTA and with the interest and drive to make a real contribution to the Board;
  • Ability to provide effective scrutiny and challenge to the Executive and to hold them to account for the delivery of performance and the delivery of its strategy;
  • Ability to think strategically and to exercise sound judgement on complex and sensitive issues; and
  • The highest standards of personal propriety in relation to governance, accountability, risk and financial management.

 In addition, candidates should bring skills and experience in one of the following areas:

Digital Transformation

  • A technology expert familiar with modern digital technology and data management techniques, with experience of successfully rolling out and scaling new technology and an understanding of the contribution this can make to improving quality and transforming processes.

Financial/Organisation Transformation

  • Experience in leading large organisations through significant transformation, with an understanding of the importance of risk management and audit to good governance, and a record of achievement at a senior level in strategic financial management.

Additional Information

The HTA’s key priority is to maintain public and professional confidence in the removal, storage and use of human tissue by ensuring that these activities are undertaken safely and ethically, and with proper consent.

The HTA was established as an Executive Non-Departmental Public Body on 1 April 2005 under the Human Tissue Act 2004.  It also acts as a Competent Authority in relation to EU legislation covering tissues and cells used in patient treatment, and organ donation and transplantation.

The HTA licences organisations that remove, store and use human tissue and organs for purposes such as research, transplantation, post mortem examination, anatomical examination and public display, as set out in its governing legislation.  The HTA publishes Codes of Practice and Standards relating to the conduct of activities within its remit, and superintends compliance with standards through a risk-based programme of audit and inspection.  It also plays a regulatory role in living organ donation, ensuring that valid consent is given and no coercion or reward takes place.

The HTA’s remit under the Human Tissue Act extends to England, Wales and Northern Ireland. It also carries out some functions (in relation to EU legislation, regulating living donation, and keeping of registers), on behalf of the Scottish Government.  Since December 2015, the Human Transplantation (Wales) Act 2013 has governed consent for organ and tissue donation in Wales, for which the HTA has produced a Code of Practice and oversees compliance.

The HTA underwent a Triennial Review in 2015, with key findings including:  clear evidence that it performs necessary functions to a high standard, and that it is very highly regarded by the large majority of stakeholders from whom the team received views. The HTA’s actions have been completed and it is preparing an overarching report on all recommendations this autumn.

In addition to its roles in licensing, inspection and approving living organ donations, the HTA has a statutory duty to provide advice and guidance to the public, and professionals, on activities within its remit.  It also has a duty to monitor developments and advise the Secretary of State, and counterparts in devolved administrations, on related issues.

As a regulator, the HTA seeks to work with stakeholders to encourage improvement, remaining accessible and responsive to a changing environment and the needs of the organisations it regulates. It is regarded as being in a unique position to comment and offer guidance on challenging issues which fall on the edge of its regulatory remit.

Recent issues which the HTA has worked with others to provide advice on include;

  • Cryopreservation of bodies;
  • Disposal of foetal remains;
  • Websites seeking to match organ donors and recipients;
  • Plans to develop a taphonomy facility in the UK (a body farm);
  • Winter capacity and contingency preparations for mortuaries;
  • EU Exit preparedness

 

The HTA works closely with other regulators and industry to ensure that regulation supports innovation, whilst protecting public confidence.

An example of this is the Regulatory Advice Service for Regenerative Medicine (RASRM), which is a ‘One Stop Shop’ for research and development professionals across academia, industry, and the NHS.

HTA has also been working closely with the Science Research and Evidence team at the Department of Health and Social Care, and using its specialist knowledge and expertise to provide significant input to the Government’s response to the House of Commons Science and Technology Select Committee’s report into Regenerative Medicine.

In the context of Government focus on its industrial strategy and the life sciences, HTA has identified various opportunities for improving the current legislative framework. This will become ever more necessary as the technology and science moves on and regulation will need to remain apace.

The Authority’s Chair and Members are appointed by the Secretary of State for Health and Social Care. The Chair and half of the members are lay, with the remainder being professionals drawn from some of the groups who are affected by the legislation.

This year, the HTA will be holding its public Authority meeting on 9th May 2019.

Link to

Attachments
DHSC diversity & monitoring form (PA)
GIS_Form.doc
HTA_Member Candidate Information pack_Ext_Final
Return to Search